Swedish startup solves the chickpea-milling problem blocking egg-replacement proteins

What Happened

Angry Camel AB patented a milling pre-treatment that finally makes chickpeas compatible with supercritical-CO2 extraction — a solvent-free process already used for soy and rapeseed — opening a path to chickpea protein as a sustainable, allergen-friendly substitute for egg white and lecithin.

Why It Matters

Supercritical-CO2 extraction is solvent-free and already proven at industrial scale for soy and rapeseed — the milling pre-treatment is a small-sounding fix that unlocks a whole existing extraction infrastructure for a new, allergen-friendlier crop.

The fix wasn't the extraction — it was the milling step before it.

FET's Takeaway

Egg white and lecithin replacement is a genuinely underserved allergen category — most plant-protein R&D chases soy and dairy alternatives, so a real chickpea-based functional substitute for egg proteins is a narrower but less crowded opportunity.